Tonghua Golden-Horse Stock Hits Day Low of CNY 15.61 Amid Price Pressure

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. experienced a significant decline today, with the stock dropping by 4.85% to reach an intraday low of CNY 15.61. This performance is notably weaker compared to the broader market, as the China Shanghai Composite index fell by only 2.06% during the same period. Over the past week, Tonghua Golden-Horse has seen a cumulative decline of 9.35%, and its performance over the last month has been even more pronounced, with a decrease of 37.92%. Year-to-date, the stock has plummeted by 42.89%, contrasting sharply with the China Shanghai Composite's modest decline of 1.39%. The company's financial metrics reveal challenges, including a low Return on Capital Employed (ROCE) of 2.62% and a Return on Equity (ROE) of just 1.37%. Additionally, the firm has reported negative results for the last three consecutive quarters, with net profit declining by 58.14%. Despite being net-debt free, the company has struggled with long-term growth, as evidenced by a negative annual growth rate in net sales of 2.78% over the past five years.